Trial Profile
Comparison of efficacy of intravitreal Aflibercept to intravitreal Ranibizumab therapy in patients with diabetic macular edema
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 May 2018
Price :
$35
*
At a glance
- Drugs Aflibercept (Primary) ; Ranibizumab
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- 02 May 2018 New trial record